Analyst Ratings for Cellectar Biosciences (CLRB)
CLRB Rating Summary
CLRB Price Target Summary
- Highest: $12.00 (Oppenheimer)
- Lowest: $12.00 (Oppenheimer)
- Average: $12.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.00 (+285.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/18/2022 | Oppenheimer » Updated 4/1/2024 |
Jeff Jones | New Coverage | Outperform (N/A) |
12.00 (11.00) |
0.43 (3.11) |
623.26% | Details |
| 4/7/2022 | Ladenburg Thalmann » Updated 11/8/2022 |
Ahu Demir | New Coverage | Buy (N/A) |
15.00 (50.00) |
0.65 (3.11) |
378.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
